1.Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients. (Quelle: Bjerkenstedt L, Edman GV, Alken RG, Mannel M., Eur Arch Psychiatry Clin Neurosci, 2005 Feb;255(1):40-7. Epub 2004 Nov 12)

2. A Double-blind, Randomized Trial of St John' Wort, Fluoxetine, and Placebo in Major Depressive Disorder. (Quelle: Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF., J Clin Psychopharmacol., 2005 Oct; 25(5):441-7)

3. An open-label pilot study of St. John's wort in juvenile depression. (Quelle: Findling RL, McNamara NK, O'Riordan MA, Reed MD, Demeter CA, Branicky LA, Blumer JL., J Am Acad Child Adolesc Psychiatry, 2003 Aug;42(8):908-14)

4. The interaction between St John's wort and an oral contraceptive. (Quelle: Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC., Clin Pharmacol Ther., 2003 Dec;74(6):525-35)

5. Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode. (Quelle: Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M., Wien Med Wochenschr., 2007;157(13-14):362-6.)

6. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials. (Quelle: Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ., Eur Arch Psychiatry Clin Neurosci., 2008 Feb;258(1):59-63. Epub 2007 Dec 14.)

7. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design (Quelle: Kasper S, Dienel A, Kieser M., Int J Methods Psychiatr Res., 2004;13(3):176-83.)

8. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572. (Quelle: Kieser M, Szegedi A., Pharmacopsychiatry., 2005 Sep;38(5):194-200.)

9. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. (Quelle: Muller T, Mannel M, Murck H, Rahlfs VW., Psychosom Med, 2004 Jul-Aug;66(4):538-47)

10. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics. (Quelle: Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T, Walter-Sack I, Haefeli WE, Mikus G., Clin Pharmacol Ther., 2005 Jul;78(1):19-24.)

11. Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men. (Quelle: Schulz HU, Schurer M, Bassler D, Weiser D., Arzneimittelforschung, 2006;56(3):212-21)

12. Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial. (Quelle: Uebelhack R, Gruenwald J, Graubaum HJ, Busch R., Adv Ther., 2004 Jul-Aug;21(4):265-75)

13. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. (Quelle: Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ, Gadde KM, Krishnan KR, Davidson JR., J Clin Psychopharmacol., 2005 Jun;25(3):243-9)